Synapse: Law for Life Sciences

 

 

 

 

Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Global Data Protection Guide
The Unified Patent Court guide
Planning for Brexit - find out what your need to know for your business
View our Global IP Index map and compare IP regimes around the world
visit the Taylor Wessing Patent Map
Subscribe to Synapse

What is the significance of the Supreme Court decision on "pemetrexed disodium"?

 

Paul England discusses the significance of the recent Supreme Court decision on "pemetrexed disodium" in Actavis UK Limited & Ors v Eli Lilly and Co.

 

 

arrowView our previous articles

Topical Issues

 

CJEU rules no authorisation of health claims made on glucose - Manja Epping and Andrea Sautter discuss the recent CJEU decision... read more

 

The Netherlands adopts statutory ban on improper inducements for medical devices - Carreen Shannon explains the new rules surrounding the inducement prohibition in the feild of medical devices in the Netherlands......read more

 

What is the current status of the UPC and Unitary Patent (August 2017 update)? - Paul England and Britta Bröker discuss the current status of the UPC and the Unitary Patent...read more

 

Court of Appeal upholds ruling that proposed parallel importation would infringe Flynn trade mark - Christopher and Timothy discuss the recent case of Flynn Pharma Ltd v DrugsRus... read more

 

Finding Nimoral Trade Mark to be confusingly similar- Christopher and Andi examine the case of Azanta A/S v EUIPO – Novartis (NIMORAL)... read more

 

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here